Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 271,513 | 298,932 | 333,395 | 341,016 | 308,304 |
| Receivables | 148,474 | 81,464 | 75,933 | 73,331 | 120,479 |
| Inventories | 74,002 | 81,160 | 96,674 | 88,200 | 60,887 |
| Other current assets | 0 | 0 | 0 | 0 | 29,282 |
| TOTAL | $510,218 | $479,995 | $528,047 | $528,160 | $537,410 |
| Non-Current Assets | |||||
| PPE Net | 376,448 | 362,544 | 359,034 | 342,083 | 327,808 |
| Intangibles | 74,866 | 76,420 | 107,547 | 109,912 | 81,759 |
| Other Non-Current Assets | 8,579 | 13,067 | 61,838 | 55,742 | 90,507 |
| TOTAL | $459,893 | $452,031 | $528,419 | $507,737 | $500,074 |
| Total Assets | $970,111 | $932,026 | $1,056,466 | $1,035,897 | $1,037,484 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,649 | 46,342 | 58,974 | 45,611 | 37,970 |
| Accrued Expenses | 40,905 | 36,381 | 32,260 | 30,715 | 38,205 |
| Other current liabilities | 3,266 | 2,759 | 5,495 | 4,540 | 2,109 |
| TOTAL | $105,856 | $110,306 | $103,858 | $90,455 | $99,611 |
| Non-Current Liabilities | |||||
| Long Term Debt | 248,094 | 247,793 | 247,393 | 247,192 | 246,892 |
| Deferred Revenues | 7,036 | 4,824 | 7,129 | 9,589 | 3,979 |
| Other Non-Current Liabilities | 11,523 | 21,609 | 24,133 | 24,451 | 27,538 |
| TOTAL | $268,050 | $274,097 | $279,936 | $278,460 | $277,856 |
| Total Liabilities | $373,906 | $384,403 | $383,794 | $368,915 | $377,467 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,688 | 40,498 | 40,459 | 40,061 | 39,474 |
| Common Shares | 41 | 41 | 41 | 40 | 40 |
| Retained earnings | 254,480 | 214,686 | 344,184 | 355,130 | 351,139 |
| Other shareholders' equity | -4,751 | -3,992 | -3,500 | -4,572 | -3,133 |
| TOTAL | $596,205 | $547,623 | $672,672 | $666,982 | $660,017 |
| Total Liabilities And Equity | $970,111 | $932,026 | $1,056,466 | $1,035,897 | $1,037,484 |